The aim was to study the changes in the antimicrobial resistance of MRSA clones over a five-year period (from 2000 to 2005) at a representative hospital in Beijing, China. A total of 100 randomly selected MRSA strains were analyzed using antimicrobial susceptibility testing, pulsed-field gel electrophoresis (PFGE), spa typing, MLST, SCCmec typing and PCR for the Panton-Valentine leukocidin (PVL) virulence factor. Resistance to rifampin increased greatly from 32% (16/50) to 68% (34/50). High-level mupirocin-resistant isolates were found only in 2005, when four were identified. Intermediate susceptibly to quinupristin-dalfopristin increased from 22% (11/50) to 52% (26/50)
INTRODUCTION
Staphylococcus aureus（S .aureus）has became as a very important pathogen that causes several diseases, ranging from minor infections of the skin to wound infections, bacteremia and necrotizing pneumonia. The epidemiological characteristics of S. aureus, especially methicillin-resistant S. aureus (MRSA), are changing rapidly. From the fist MRSA strain reported until the present, various hospital-associated MRSA (HA-MRSA) clones have been disseminated worldwide (3, 5, 6, 12, 26) . The emergence of new strains of community-associated MRSA (CA-MRSA) in many parts of the world is well documented (15, 21) and causes an increasing proportion of healthcare-associated infections (13) .
In China, MRSA is highly endemic in hospitals with mean prevalence rates of >50% in 2005 (33) .Two major epidemic MRSA clones with a unique geographic distribution across China, ST239-MRSA-III and ST5-MRSA-II have been reported recently (22) . Multilocus sequence typing (MLST) for a few isolates over five years was completed by us and provided an important clue (34) . In order to investigate the dynamics of MRSA over long time periods, we characterized MRSA isolates from a Chinese hospital collected between 2000 and 2005 to identify changes in antimicrobial resistance, molecular typing and virulence factors.
MATERIALS AND METHODS

Isolates
A total of 100 MRSA strains were isolated from several clinical sources (including the respiratory tract (n=76), blood (n=3), drainage (n=8), pus (=7), wounds (n=3), and other sources (n =3) that were randomly selected from Beijing Union Medical Hospital, which has about 1800 beds. Fifty strains were isolated in 2000, and 50 more were isolated in 2005. All strains were confirmed by PCR analysis of the mecA and nuc genes (4).
Antimicrobial susceptibility tests
A total of 14 antimicrobial agents were tested, including linezolid, chloramphenicol, tetracycline, gentamicin, vancomycin, ciprofloxacin, erythromycin, clindamycin, rifampin, quinupristin-dalfopristin, teicoplanin, mupirocin, fusidic acid and trimethoprim. Vancomycin was tested by broth dilution according to CLSI, and the other antimicrobial agents were tested by Etest (AB Biodisk, Solna, Sweden). CLSI breakpoints were used for MIC interpretation. The resistance breakpoints for mupirocin and fusidic acid were defined as described previously (9, 23) . BioNumerics software (v. 4.6, Bio-Rad) using the Dice coefficient and were represented by unweighted pair group method arithmetic averages (UPGMA) with 1.5% tolerance and 1% optimization settings. A similarity cutoff of 80% and the criterion of a difference of 6 bands as described by Tenover (30) were used to define a cluster. Isolates showing identical or related PFGE patterns were considered to belong to the same clone. Clones were labeled with a capital letter (A, B, C, and so on), and related profiles were indicated by adding a number (A1, A2, B1, B2, and so on).
Molecular typing
Spa typing, MLST and SCCmec typing were performed as previously described (7, 8, 14, 27, 35) .
pvl and mupA genes detection Panton-Valentine leukocidin (PVL) genes (lukS-PV and lukF-PV) were detected by PCR (21) . The high-level mupirocin-resistant isolates (based on the Etest method) were detected by PCR for the mupA gene as described previously (1).
Statistical analysis
Statistical analysis was performed with the SPSS software package using chi-square and Fisher's exact tests.
RESULTS
Antimicrobial susceptibility testing
Isolates from the various time periods did not demonstrate resistance or increases in the MIC On the other hand, gentamicin, quinupristin-dalfopristin, fusidic acid and trimethoprim resistance decreased from 100% to 94%, 12% to 8%, 4% to 0% and 4% to 0% respectively.
Antibiotic resistance profiles and molecular epidemiology
Overall, fifteen PFGE strain types ( (Table 1) .
Typing all isolates yielded five spa types ( 
Discussion
MRSA strains associated with community acquisition were not found to have been introduced into this hospital, but there were epidemiological changes in the types of HA-MRSA strains in the facility over the five years included in our study, with an associated change in antimicrobial resistance patterns.
The main antimicrobial resistance profile changed from TC-GM-CI-EM-CM in 2000 to TC-GM-CI-EM-CM-RI in 2005. Resistance to rifampin increased from 32% to 68%, and the MIC50 for rifampin increased from 0.008 to 256μg/ml. Combination therapy with rifampin has been used to treat S aureus infections (24, 29) and has been widely used in China in recent years to treat esophagitis, dysentery (difficult to cure or resistant), skin infections, hordeolum, purulent otitis media and mycoplasma pneumonia. From our data, we found that an increasing number of resistant isolates are emerging with the wide spread use of rifampin.
The data in this study revealed that resistance to mupirocin increased from 2% to 8%. We found four high-level-resistant (MupRH) isolates with mupA in 2005 (11), which were PFGE types F and H, belonged to the same spa type and STs (t002, ST5-MRSA-II), and belonged
to two antimicrobial resistant profiles (CL-TC-GM-CI-EM-CM-MU and TC-CI-EM-CM-MU).
One low-level-resistant (MupRL) (2, 10) We thank Beijing Union Medical Hospital for the MRSA isolates supported.
